Navigation Links
SCOLR Pharma, Inc. Reports Third Quarter 2010 Financial Results
Date:11/10/2010

//www.scolr.com/.

This press release contains forward-looking statements (statements which are not historical facts) within the meaning of the Private Securities Litigation Reform Act of 1995, including statements concerning anticipated sales of our nutritional products and the timing thereof, the timing of anticipated shipment of our nutritional products, our expectations concerning conduct of the actual use study for our ibuprofen product, our expectations concerning regulatory approval of our pseudoephedrine product and the anticipated timing of such approval. These forward-looking statements involve risks and uncertainties, including activities, events or developments that we expect, believe or anticipate will or may occur in the future. A number of factors could cause actual results to differ from those indicated in the forward-looking statements, including lower than expected demand by national retailers for our nutritional products, our ability to conform to the sales planning cycles of the retailers targeted as potential customers for our nutritional products, constraints on our liquidity related to the greater working capital requirements of our nutritional business, unanticipated changes in the timing or amount of orders for our nutritional products, unanticipated problems or delays with our regulatory applications, unanticipated costs and expenses associated with our product development, clinical activities and regulatory review,  reductions in our royalty revenues, our ability to create and maintain partnerships or other relationships, the continuation of arrangements with our product development partners, customers and clinical project services providers, competition, government regulation and general economic conditions. For example, if we are not able to meet the timing and other expectations of the retailers we have targeted as potential customers of our nutritional products, we may not be able to generate revenue from sales of these
'/>"/>

SOURCE SCOLR Pharma, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. SCOLR Pharma, Inc. Names Carl Johnson as Chairman; Former Chairman Michael Taglich Remains as Director
2. SCOLR Pharma, Inc. Signs Agreement with The Emerson Group to Provide Sales Support for Nutritional & OTC Products
3. SCOLR Pharma, Inc. Enters into Worldwide Licensing Agreement with RedHill Biopharma Ltd.
4. SCOLR Pharma, Inc. Licenses Dietary Supplements
5. SCOLR Pharma, Inc. Receives Notices From NYSE Amex LLC Regarding Compliance Plan and Listing Standards
6. SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results
7. SCOLR Pharma, Inc. Reports Third Quarter 2008 Financial Results
8. SCOLR Pharma Announces Completion of Patient Enrollment and Dosing for Pivotal Clinical Trial Evaluating Extended Release Ibuprofen
9. Reportlinker Adds Merger and Acquisition Terms and Agreements in Pharma, Biotech and Diagnostics, 4th edition
10. Reportlinker Adds Co-promotion and Co-marketing Agreements in Pharma, Biotech and Diagnostics, 4th Edition
11. Horizon Pharma, Inc. Files Registration Statement for Proposed Initial Public Offering
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/29/2014)... , Sept. 29, 2014 Pharmaceutical Care Management ... today outlined policy solutions that could reduce prescription fraud ... Hill briefing, " Prescription Opioid Abuse: Fighting Back on ... Reform and PCMA. The briefing featured ... prescription drug abuse and fraud. The Centers for Disease ...
(Date:9/29/2014)... YORK , Sept. 29, 2014 ... Summary GlobalData,s new report, "EU5 Esophagoscopes ... market data on the EU5 Esophagoscopes & Gastroscopes ... US dollars, volume (in units) and average prices ... Video Esophagoscopes, Flexible Non-Video (Fibre) Gastroscopes and Flexible ...
(Date:9/29/2014)... BEIJING , Sept. 29, 2014  Following US and ... accelerator, the China Food and Drug Administration (CFDA) has ... in the country. According to the International ... people are diagnosed with cancer every year in ... types including lung, gastric, colorectal, liver and esophageal cancers ...
Breaking Medicine Technology:PCMA: How Congress Can Fight Prescription Drug Fraud and Abuse 2EU5 Esophagoscopes & Gastroscopes Market Outlook to 2020 2EU5 Esophagoscopes & Gastroscopes Market Outlook to 2020 3Chinese clinics and cancer patients to benefit from Elekta's Versa HD radiation therapy system 2Chinese clinics and cancer patients to benefit from Elekta's Versa HD radiation therapy system 3
... DIEGO, Dec. 18 Ambrx Inc. today announced ... with Merck & Co. Inc. to,develop a novel ... Factor 21 (FGF-21) for the treatment of type ... The collaboration utilizes Ambrx,s proprietary protein technology,ReCODE(TM), ...
... Epeius Biotechnologies,Corporation announced today that the company ... Rexin-G(R) from the Philippine Bureau of Food ... lead product as a safe,and effective treatment ... as a tumor-targeted anticancer agent, that actively ...
Cached Medicine Technology:Ambrx Enters FGF-21 Type 2 Diabetes Drug Discovery Collaboration with Merck and Co. Inc. 2ASEAN News: Epeius Biotechnologies Gains Commercial Approval for Rexin-G(R), a Tumor-Targeted Gene-Based Medicine for Metastatic Cancer 2ASEAN News: Epeius Biotechnologies Gains Commercial Approval for Rexin-G(R), a Tumor-Targeted Gene-Based Medicine for Metastatic Cancer 3
(Date:9/30/2014)... 2014 Visiting Nurse Association (VNA) Health ... to announce that Steven Landers, MD, MPH, president and ... “40 Under 40” award on Monday evening. The NJBIZ ... businessmen and women who have been making headlines in ... growth, professional excellence and to the community. , Dr. ...
(Date:9/30/2014)... Louis, Missouri (PRWEB) September 30, 2014 ... announce that the SLUCare Physician Group, comprised of more ... collaborating on a number of initiatives. With the ... its network size, strengthening its market footprint to better ... St. Louis area. , SLPA is a physician-led clinically ...
(Date:9/30/2014)... September 30, 2014 The global market ... USD 38.75 billion by 2020 at an estimated CAGR ... new study by Grand View Research, Inc. Increasing prevalence ... lifestyle habits such as excessive alcohol consumption and growing ... rates is expected to serve this market as a ...
(Date:9/30/2014)... 2014 Lea Blackwell, M.D., a Breast ... patients a new, more practical and comfortable option for ... mastectomies, biopsies and lumpectomy surgeries use special bras after ... seeing her patients describe the bra as scratchy, uncomfortable ... new bra in her spare time. , Ilona ...
(Date:9/30/2014)... Red Bank, NJ (PRWEB) September 30, 2014 ... largest not-for-profit visiting nurse association—is pleased to announce that ... was honored with a NJBIZ “40 Under 40” ... of New Jersey’s most accomplished young businessmen and women ... who share a commitment to business growth, professional excellence ...
Breaking Medicine News(10 mins):Health News:Visiting Nurse Association Health Group’s Dr. Steven Landers Honored with NJ BIZ “40 Under 40” Award 2Health News:Visiting Nurse Association Health Group’s Dr. Steven Landers Honored with NJ BIZ “40 Under 40” Award 3Health News:St. Louis Physician Alliance Expands Network and Market Footprint with Recent Addition of SLUCare Physician Group 2Health News:Global Artificial Organ & Bionics Market Is Expecting Growth At CAGR Of 40.0% In Brain Bionics Segment From 2014 To 2020: Grand View Research, Inc. 2Health News:Global Artificial Organ & Bionics Market Is Expecting Growth At CAGR Of 40.0% In Brain Bionics Segment From 2014 To 2020: Grand View Research, Inc. 3Health News:Global Artificial Organ & Bionics Market Is Expecting Growth At CAGR Of 40.0% In Brain Bionics Segment From 2014 To 2020: Grand View Research, Inc. 4Health News:Global Artificial Organ & Bionics Market Is Expecting Growth At CAGR Of 40.0% In Brain Bionics Segment From 2014 To 2020: Grand View Research, Inc. 5Health News:Global Artificial Organ & Bionics Market Is Expecting Growth At CAGR Of 40.0% In Brain Bionics Segment From 2014 To 2020: Grand View Research, Inc. 6Health News:Surgeon Creates New Bra for Breast Cancer Patients, Post-Surgery 2Health News:Surgeon Creates New Bra for Breast Cancer Patients, Post-Surgery 3Health News:Visiting Nurse Association Health Group’s Dr. Steven Landers Honored with NJ BIZ “40 Under 40” Award 2Health News:Visiting Nurse Association Health Group’s Dr. Steven Landers Honored with NJ BIZ “40 Under 40” Award 3
... ... , ... , ... ...
... The adverse affects of being overweight are not limited to ... research in the latest issue of the Journals ... (Volume 65A, Number 1). The publication presents a collection ... older persons. "One of the unanticipated consequences of ...
... exposure time , TUESDAY, Feb. 23 (HealthDay News) -- ... as much as 91 percent less radiation than standard ... generated great enthusiasm in recent years, due to its ... coronary artery disease. However, that enthusiasm has been tempered ...
... to develop dementia than non-hospitalized, study finds , TUESDAY, ... hospitalized have an increased risk of cognitive decline. , That,s ... through 2007 on 2,929 people, aged 65 and older, who ... During an average follow-up of 6.1 years, 1,287 were hospitalized ...
... ... ... ... ...
... stress hormone levels in adolescent boys and girls but ... researchers. Early treatment of depression could help reduce stress ... "This is the first time cortisol reactivity has ... obesity in girls," said Elizabeth J. Susman, the Jean ...
Cached Medicine News:Health News:Universal Health Realty Income Trust Reports 2009 Fourth Quarter and Full Year Financial Results 2Health News:Universal Health Realty Income Trust Reports 2009 Fourth Quarter and Full Year Financial Results 3Health News:Universal Health Realty Income Trust Reports 2009 Fourth Quarter and Full Year Financial Results 4Health News:Universal Health Realty Income Trust Reports 2009 Fourth Quarter and Full Year Financial Results 5Health News:Universal Health Realty Income Trust Reports 2009 Fourth Quarter and Full Year Financial Results 6Health News:Universal Health Realty Income Trust Reports 2009 Fourth Quarter and Full Year Financial Results 7Health News:Universal Health Realty Income Trust Reports 2009 Fourth Quarter and Full Year Financial Results 8Health News:Universal Health Realty Income Trust Reports 2009 Fourth Quarter and Full Year Financial Results 9Health News:Universal Health Realty Income Trust Reports 2009 Fourth Quarter and Full Year Financial Results 10Health News:Universal Health Realty Income Trust Reports 2009 Fourth Quarter and Full Year Financial Results 11Health News:Universal Health Realty Income Trust Reports 2009 Fourth Quarter and Full Year Financial Results 12Health News:Universal Health Realty Income Trust Reports 2009 Fourth Quarter and Full Year Financial Results 13Health News:Universal Health Realty Income Trust Reports 2009 Fourth Quarter and Full Year Financial Results 14Health News:Universal Health Realty Income Trust Reports 2009 Fourth Quarter and Full Year Financial Results 15Health News:Universal Health Realty Income Trust Reports 2009 Fourth Quarter and Full Year Financial Results 16Health News:Universal Health Realty Income Trust Reports 2009 Fourth Quarter and Full Year Financial Results 17Health News:Universal Health Realty Income Trust Reports 2009 Fourth Quarter and Full Year Financial Results 18Health News:Overweight middle-aged adults at greater risk for cognitive decline in later life 2Health News:New Heart CT Scans Deliver Far Less Radiation: Study 2Health News:Hospital Stays May Spur Brain Decline in Seniors 2Health News:Stopain Labels Featuring Arthritis Foundation Sponsorship Now Appearing on Retail Shelves 2Health News:Stopain Labels Featuring Arthritis Foundation Sponsorship Now Appearing on Retail Shelves 3Health News:Stopain Labels Featuring Arthritis Foundation Sponsorship Now Appearing on Retail Shelves 4Health News:Stress hormone, depression trigger obesity in girls 2
Used for vascular access. Supplied sterile in peel-open packages. Intended for one-time use....
Used for placement of .035 inch (0.89 mm) or .038 inch (0.97 mm) diameter wire guides into the vascular system when a small 24 gage needle stick is desired....
Used to introduce large devices for vascular intervention....
Used to introduce large balloon, closed and non-tapered end catheters or other devices for intervention....
Medicine Products: